Combination with basal insulin In a 30-week, double-blind trial (NCT02305381), 397 patients with type 2 diabetes mellitus inadequately controlled with basal insulin, with or without metformin, were randomized to OZEMPIC 0.5 mg once weekly, OZEMPIC 1 mg once weekly, or placebo
Retrospective studies are inconsistent
The first is that CT is a secretory peptide whose secretion is episodic and may be affected by the ambient plasma calcium concentration, exercise, eating (gastrin stimulation), or other poorly defined stimuli
Pharmacies use pharmaceutical-grade ingredients under a clinician's direction and meet certain FDA quality standards, but the final compounded product is not FDA-approved
Schulte-Hermann, R., and Parzefall, W
(Source: Liang et al (2023))